How Interferon Type I Protects Airway Cells from Rhinovirus Infections
Author Information
Author(s): Boland Helena, Endres Adrian, Kinscherf Ralf, Schubert Ralf, Wilhelm Beate, Schwarzbach Hans, Jonigk Danny, Braubach Peter, Rohde Gernot
Primary Institution: Johann Wolfgang Goethe-Universität, Frankfurt am Main
Hypothesis
Can type I interferons protect against virus-induced epithelial barrier dysfunction during rhinovirus infections?
Conclusion
Interferon-β1a pre-treatment effectively protects airway epithelial cells from damage caused by rhinovirus infections.
Supporting Evidence
- IFN-β1a pre-treatment reduced viral RNA copies by up to 99.8%.
- HRV infection significantly damaged tight junctions in untreated cells.
- Pre-treatment with IFN-β1a maintained barrier integrity during viral infection.
- IFN-β1a reduced the number of dead cells in infected cultures.
- TEER measurements showed that IFN-β1a pre-treatment prevented the drop in barrier function.
Takeaway
This study shows that a special protein called interferon can help protect the cells in our lungs from getting hurt by a virus that causes colds.
Methodology
Differentiated primary bronchial epithelial cells were pre-treated with IFN-β1a and then infected with human rhinovirus to assess barrier function and cell viability.
Limitations
The study was conducted in vitro, which may not fully replicate in vivo conditions.
Participant Demographics
Primary bronchial epithelial cells were isolated from lung explant tissue of four cystic fibrosis patients.
Statistical Information
P-Value
0.021
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website